Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered immune cells with receptor cross-talk

Engineered immune cells with receptor cross-talk

US Patent 11976297 · Granted May 7, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered immune cells with receptor signal strength modulated by a hinge2025
Engineered immune cells with dominant signals2025
Engineered immune cells with receptor signal strength modulated by a hinge2024
MTS2 gene2001
Mouse MTS2 gene2001
MTS2 gene2001
17q-linked breast and ovarian cancer susceptibility gene2000
Antibodies specific for MTS2 Polypeptide2000
Chromosome 13-linked breast cancer susceptibility gene2000
MTS1 gene2000
Methods for measuring relative amounts of nucleic acids in a complex mixture and2000
Vector containing MTS1E1.beta. gene2000